Cabio Biotech (Wuhan) Co., Ltd.

¥7.66As of Sun 8 Nov 2026, 12:00 UTC
SSE:688089Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR (15.87%)
Div yield —
ROE (15.27%)
Biotechnology
Beta (5Y) 0.59
PE TTM —
TSR TTM (68.46%)
Mkt cap ¥1.288B
ROIC (9.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.82
2.15%
(21.39%)
Hold 10|2|11|10|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.14
0.14
0.14
23.26%
25.04%
20.75%
13.12%
Revenue¥M
118.4
122.1
126.6
125.9
15.18%
15.35%
14.87%
8.97%
Peers (US$193.0M)
Cap (US$)
PE
173.9M
—
192.9M
—
Capital
TTM
5Y
10Y
Leveragex
4.266
(0.105)
(0.092)
EBIT/Intx
0.354
1.898
1.725
Own earn%
(30.46)
(48.38)
(48.05)
Sh yield%
35.20
23.63
23.16
Owners
Insiders/Inst%
7.69
26.61
Short interest%
5.90
SBC / revenue%
0.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
33–36
$1 testx
0.5
Incr. ROIC%
4